One-year results of golimumab compared with placebo in patients with active RA despite treatment with methotrexate: A phase II, randomized, double-blind, placebo-controlled, dose-ranging trial.

Kay, J.; Durez, Patrick; Matteson, E. L.; Dasgupta, B.; Nash, P.; Hall, S.; Hsia, E. C.; Chiruvolu, P.; Han, J.; Rahman, M. U.

One-year results of golimumab compared with placebo in patients with active RA despite treatment with methotrexate: A phase II, randomized, double-blind, placebo-controlled, dose-ranging trial.

Kay, J.

;

Durez, Patrick

;

Matteson, E. L.

;

Dasgupta, B.

;

Rahman, M. U.

;et.al.

(2006) 70th Annual Scientific Meeting of the American-College-of-Rheumatology/41st Annual Scientific Meeting of the Association-of-Rheumatology-Health-Professionals — Location: Washington (Dc) (10.November.2006)

Files

No attached file found for this publication.

Details

Authors

Kay, J.
Author
Durez, PatrickUCLouvain
Author
Matteson, E. L.
Author
Dasgupta, B.
Author
Rahman, M. U.
Author

Affiliations

Citations

APA
Chicago
FWB

Kay, J., Durez, P., Matteson, E. L., Dasgupta, B., Nash, P., Hall, S., Hsia, E. C., Chiruvolu, P., Han, J., & Rahman, M. U. (2006). One-year results of golimumab compared with placebo in patients with active RA despite treatment with methotrexate: A phase II, randomized, double-blind, placebo-controlled, dose-ranging trial. Arthritis & Rheumatism, 54(9), S833-S833. https://hdl.handle.net/2078.5/139792 (Original work published 2006)